Nyxoah (NYXH) Liabilities and Shareholders Equity (2020 - 2026)
Nyxoah (NYXH) recorded quarterly Liabilities and Shareholders Equity of $114.3 million in Q1 2026, down 17.16% quarter-over-quarter from $137.9 million in Q4 2025, and down 20.07% on a YoY basis from $143.0 million in Q1 2025.
Nyxoah (NYXH) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
Nyxoah's Liabilities and Shareholders Equity history runs 7 years deep, the most recent figure standing at $114.3 million for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity fell 20.07% year-over-year to $114.3 million; the TTM figure through Mar 2026 stood at $384.0 million (down 38.91% YoY), while the FY2025 annual figure was $137.9 million, down 18.51% from the prior year.
- Liabilities and Shareholders Equity was $114.3 million for Q1 2026 at Nyxoah, down from $137.9 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $186.3 million in Q1 2022 to a low of $165427.6 in Q3 2022.
- Historically, Liabilities and Shareholders Equity has averaged $140.4 million across 5 years, with a median of $147.8 million in 2023.
- The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity surged 88473.73% in 2023, then slipped 24.22% in 2024.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $149.0 million in 2022, then slipped by 10.36% to $133.6 million in 2023, then climbed by 26.71% to $169.3 million in 2024, then decreased by 18.51% to $137.9 million in 2025, then retreated by 17.16% to $114.3 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $114.3 million (Q1 2026), $137.9 million (Q4 2025), and $131.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 20.11 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 50.83 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 39.01 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 8.78 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.11 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 14.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 6.31 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 19.85 Bn |
| 10 | Nyxoah | 0.69 | 0.69 | 4.26 Mn | 114.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 114.26 Mn |
| Dec 31, 2025 | 137.94 Mn |
| Jun 30, 2025 | 131.84 Mn |
| Mar 31, 2025 | 142.95 Mn |
| Dec 31, 2024 | 169.27 Mn |
| Sep 30, 2024 | 156.79 Mn |
| Jun 30, 2024 | 159.63 Mn |
| Mar 31, 2024 | 122.78 Mn |
| Dec 31, 2023 | 133.59 Mn |
| Sep 30, 2023 | 146.53 Mn |
| Jun 30, 2023 | 155.08 Mn |
| Mar 31, 2023 | 162.02 Mn |
| Dec 31, 2022 | 149.03 Mn |
| Sep 30, 2022 | 165,427.57 |
| Jun 30, 2022 | 178.07 Mn |
| Mar 31, 2022 | 186.28 Mn |
| Dec 31, 2021 | 195.42 Mn |
| Dec 31, 2020 | 136.02 Mn |